by Imperial College London The researchers behind the early-stage work, published in JCI Insight, are exploring whether kisspeptin can ultimately be used to treat men with common psychosexual disorders—sexual problems which are psychological in origin such as low libido. The team are now hoping to perform trials in patients with low sexual desire. The team...
